• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症模型中食管疾病的系列内镜评估:食管腺癌(EAC)药物发现与开发的范式转变

Serial Endoscopic Evaluation of Esophageal Disease in a Cancer Model: A Paradigm Shift for Esophageal Adenocarcinoma (EAC) Drug Discovery and Development.

作者信息

Omstead Ashten N, Kosovec Juliann E, Matsui Daisuke, Martin Samantha A, Smith Matthew A, Aaron Guel D, Kolano Jenna, Komatsu Yoshihiro, Habib Fahim, Lai Christopher, Christopher Kevi, Kelly Ronan J, Zaidi Ali H, Jobe Blair A

机构信息

a Esophageal and Lung Institute , Allegheny Health Network , Pittsburgh , PA , USA.

b Department of Gastroenterological Surgery , Kanazawa University Hospital , Kanazawa , Ishikawa , Japan.

出版信息

Cancer Invest. 2018;36(7):363-370. doi: 10.1080/07357907.2018.1499029. Epub 2018 Aug 24.

DOI:10.1080/07357907.2018.1499029
PMID:30142016
Abstract

A rat model of surgically induced reflux recapitulates the development and progression of human esophageal adenocarcinoma (EAC). In this study, reflux was induced in rats followed by postoperative endoscopy with biopsy, to diagnose and monitor disease progression. Overall, percentage agreement between visual endoscopy and gold standard histology was 95%, with disease-specific classification accuracies of 100% and 75% for Barrett's with dysplasia and EAC, respectively. Additionally, the percentage agreement for biopsy in tumors >4 mm was 75%. Thereby, establishing endoscopic evaluation as a reliable tool to assess disease progression and provide biopsies for downstream correlates in a de novo EAC model.

摘要

手术诱导反流的大鼠模型概括了人类食管腺癌(EAC)的发展和进程。在本研究中,对大鼠进行反流诱导,随后进行术后内镜检查及活检,以诊断和监测疾病进展。总体而言,视觉内镜检查与金标准组织学之间的百分比一致性为95%,巴雷特食管伴发育异常和EAC的疾病特异性分类准确率分别为100%和75%。此外,肿瘤>4毫米时活检的百分比一致性为75%。从而,在内生性EAC模型中,将内镜评估确立为评估疾病进展并为下游关联因素提供活检样本的可靠工具。

相似文献

1
Serial Endoscopic Evaluation of Esophageal Disease in a Cancer Model: A Paradigm Shift for Esophageal Adenocarcinoma (EAC) Drug Discovery and Development.癌症模型中食管疾病的系列内镜评估:食管腺癌(EAC)药物发现与开发的范式转变
Cancer Invest. 2018;36(7):363-370. doi: 10.1080/07357907.2018.1499029. Epub 2018 Aug 24.
2
Animal Model: Reflux Models in Esophageal Adenocarcinoma.动物模型:食管腺癌中的反流模型
Methods Mol Biol. 2018;1756:143-150. doi: 10.1007/978-1-4939-7734-5_13.
3
High yield reproducible rat model recapitulating human Barrett's carcinogenesis.高产量可重现性大鼠模型重现人类巴雷特食管癌变。
World J Gastroenterol. 2017 Sep 7;23(33):6077-6087. doi: 10.3748/wjg.v23.i33.6077.
4
Risk of neoplastic progression in Barrett's esophagus diagnosed as indefinite for dysplasia: a nationwide cohort study.诊断为不典型增生的巴雷特食管的肿瘤进展风险:一项全国性队列研究。
Endoscopy. 2015 May;47(5):409-14. doi: 10.1055/s-0034-1391091. Epub 2014 Dec 18.
5
Risk factors in the development of esophageal adenocarcinoma.食管腺癌发展的危险因素。
Am J Gastroenterol. 2013 Feb;108(2):200-7. doi: 10.1038/ajg.2012.387. Epub 2012 Dec 18.
6
Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia.发展和验证一个模型以确定 Barrett 食管进展为肿瘤的风险。
Gastroenterology. 2018 Apr;154(5):1282-1289.e2. doi: 10.1053/j.gastro.2017.12.009. Epub 2017 Dec 19.
7
Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus.巴雷特食管患者低级别上皮内瘤变进展的危险因素。
Gastroenterology. 2011 Oct;141(4):1179-86, 1186.e1. doi: 10.1053/j.gastro.2011.06.055. Epub 2011 Jun 30.
8
Clinical biology of the Barrett's metaplasia, dysplasia to carcinoma sequence.巴雷特化生、发育异常至癌变序列的临床生物学。
Surg Oncol. 2001 Nov;10(3):91-102. doi: 10.1016/s0960-7404(01)00030-5.
9
Rat Reflux Model of Esophageal Cancer and Its Implication in Human Disease.大鼠食管癌反流模型及其对人类疾病的启示。
Ann Surg. 2015 Dec;262(6):910-24. doi: 10.1097/SLA.0000000000001207.
10
From reflux esophagitis to Barrett's esophagus and esophageal adenocarcinoma.从反流性食管炎到巴雷特食管和食管腺癌。
World J Gastroenterol. 2015 May 7;21(17):5210-9. doi: 10.3748/wjg.v21.i17.5210.

引用本文的文献

1
Intratumoral immunotherapy with STING agonist, ADU-S100, induces CD8+ T-cell mediated anti-tumor immunity in an esophageal adenocarcinoma model.在食管腺癌模型中,使用STING激动剂ADU-S100进行瘤内免疫治疗可诱导CD8 + T细胞介导的抗肿瘤免疫。
Oncotarget. 2021 Feb 16;12(4):292-303. doi: 10.18632/oncotarget.27886.
2
Evidence-Based Practice Guideline for Surgical Treatment of Gastroesophageal Reflux Disease 2018.《2018年胃食管反流病手术治疗循证实践指南》
J Gastric Cancer. 2018 Dec;18(4):313-327. doi: 10.5230/jgc.2018.18.e41. Epub 2018 Dec 27.